NCT05522283 is a clinical trial of Stool and blood CMV PCR in CMV Colitis, sponsored by Mahidol University.

Who is sponsoring NCT05522283?

NCT05522283 is sponsored by Mahidol University.

What drugs are being tested in NCT05522283?

Interventions in NCT05522283: Stool and blood CMV PCR.

What condition does NCT05522283 study?

NCT05522283 studies CMV Colitis.

Is NCT05522283 still recruiting?

NCT05522283 is currently completed. Last updated 1 September 2022.

Last reviewed 2022-09-01 · How we verify

NCT05522283

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stool and Serum CMV-PCR in Diagnosing CMV Colitis

Completed Last updated 1 September 2022

What this trial tests

trial testing Stool and blood CMV PCR in CMV Colitis in 137 participants. Completed in 31 October 2021.

Timeline

1 October 2020

Primary endpoint
31 October 2021

31 October 2021

Quick facts

Lead sponsor	Mahidol University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	137
Start date	1 October 2020
Primary completion	31 October 2021
Estimated completion	31 October 2021
Sites	1 location across Thailand

Drugs / interventions tested

Stool and blood CMV PCR

Conditions studied

CMV Colitis — all drugs for CMV Colitis →

Sponsor

Mahidol University

Who can join

18 and older, any sex, with CMV Colitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CMV viral load detected by real-time polymerase chain reaction (PCR) in either serum or stool may be beneficial in diagnosing CMV colitis, but the data is limited. Therefore, we aimed to investigate the diagnostic performance of stool CMV-PCR, serum CMV-PCR, and their combination in diagnosing CMV colitis using tissue histopathology as the standard reference in patients with clinical suspicion of CMV colitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Performance of Cytomegalovirus Real-Time Polymerase Chain Reaction Assays of Fecal and Plasma Specimens for Diagnosing Cytomegalovirus Colitis.
Sattayalertyanyong O, Limsrivilai J, Phaophu P, Subdee N, et al · · 2023 · cited 8× · PMID 36854054 · DOI 10.14309/ctg.0000000000000574

Verify or expand the search:

Other Mahidol University trials

Trials by the same sponsor.

NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05522283 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mahidol University
Last refreshed: 1 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05522283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing